That data you’re waiting for should be out very soon. As you said the Cholangio Cancer is notoriously difficult. The trials have progressed 14 months since the Cholangio data was released. So it is at higher doses for more patients and also includes longer timeframes on the very important durability question.
Unfortunately IMU attracted a lot of inexperienced investors who have no experience in biotechs. They got excited by the regular groundbreaking announcements, which then dropped off as the trials ground on. Collecting the data.
Many of those impetuous investors dropped out when the overnight riches evaporated. Then blamed the CEO for their poor investment outcomes.
As we know from Dr Woodard (Oncologist) Prof Yuman Fong (genius ) and Leslie Chong CF33 works . It’s curing people of cancer.
IMU Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)